CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Psomagen Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Psomagen Inc
1330 Piccard Dr Suite 103
Phone: (301) 251-1007p:301 251-1007 ROCKVILLE, MD  20850-4352  United States Ticker: 950200950200
This is a Subsidiary, click here for the Parent Company
Business Summary
Psomagen, Inc. is an integrative omics solutions and contract laboratory services provider. The Company’s labs are United States-based and are Clinical Laboratory Improvement Amendments (CLIA) certified and include certified authorization professional (CAP) accredited facilities. Its omics services include Whole-Genome Sequencing, Whole-Exome Sequencing, Targeted Sequencing, Sanger Sequencing, Microarray Analysis, Epigenomics Sequencing, Metagenomics Sequencing, Ribonucleic acid (RNA) Sequencing, Single-Cell Sequencing and Biomarker Profiling. It also offers SARS-CoV-2 Variant Sequencing services. The Company’s Microarray Analysis is a multiplex genomics approach that targets and quantifies specific genes by hybridizing the nucleic acid to a chip and providing an output of genotyping data on a genome-wide scale. Epigenomics is the study of epigenetic changes, such as chromatin assembly, histone modification, and Deoxyribonucleic acid DNA-protein interaction in a cell.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
8071 Medical laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director SuHong 42 7/5/2022 7/5/2022

General Information
Number of Employees: 92 (As of 9/30/2023)
Outstanding Shares: 19,236,053 (As of 12/31/2023)
Shareholders: 16,239
Stock Exchange: KDQ
Fax Number: (301) 251-4006
Email Address: inquiry@psomagen.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 18, 2024